This inventor holds 1 USPTO granted patent. Top assignee: Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v.. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Tilo Knape: Innovator in PPAR-gamma Antagonists
Introduction
Tilo Knape is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target specific receptors involved in immune-related diseases. His work is characterized by a focus on innovative solutions to complex medical challenges.
Latest Patents
Tilo Knape holds a patent for a compound known as (E)-2-(5-((4-methoxy-2-(trifluoromethyl)quinolin-6-yl)methoxy)-2-((4-(trifluoromethyl)benzyl)oxy)-benzylidene) hexanoic acid (MTTB). This compound and its derivatives serve as selective peroxisome proliferator-activated receptor gamma (PPAR-γ) antagonists. The invention is particularly relevant for the treatment of immune-related diseases such as systemic inflammation, sepsis, and septic shock. He has 1 patent to his name.
Career Highlights
Tilo Knape is associated with the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., a leading research organization in Germany. His work at this institution has allowed him to explore innovative approaches to drug development and contribute to advancements in medical science.
Collaborations
Throughout his career, Tilo has collaborated with esteemed colleagues, including Michael John Parnham and Mario Wurglics. These collaborations have fostered a productive environment for research and innovation, leading to significant advancements in their respective fields.
Conclusion
Tilo Knape's contributions to the field of pharmacology, particularly through his patent on PPAR-gamma antagonists, highlight his role as an innovator in medical research. His work continues to pave the way for new treatments for immune-related diseases.